Embeline e and Ranitidine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Embeline e (clobetasol propionate) and Ranitidine (ranitidine). Common drug interactions include abdominal pain among females.
The phase IV clinical study analyzes what interactions people have when they take Embeline e and Ranitidine. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Embeline e?
Embeline e has active ingredients of clobetasol propionate. eHealthMe is studying from 37 Embeline e users. Check the latest studies of Embeline e.
What is Ranitidine?
Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.
14 people who take Embeline e and Ranitidine together, and have interactions are studied.
What are the common drug interactions of Embeline E and Ranitidine, by gender? *:
female:
- Abdominal pain
- Anaemia (lack of blood)
- Gastrointestinal pain
- Hepatic enzyme increased
- Hepatic steatosis (fatty liver disease)
- Hepatitis (inflammation of the liver)
- Hypertension (high blood pressure)
- Hypertensive crisis
- Hypertriglyceridaemia (excess of triglycerides in the blood)
- Inflammatory bowel disease
male:
n/a
What are the common drug interactions of Embeline E and Ranitidine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Abdominal pain
- Anaemia (lack of blood)
- Gastrointestinal pain
- Hepatic enzyme increased
- Hepatic steatosis (fatty liver disease)
- Hepatitis (inflammation of the liver)
- Hypertension (high blood pressure)
- Hypertensive crisis
- Hypertriglyceridaemia (excess of triglycerides in the blood)
- Inflammatory bowel disease
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
n/a
* Approximation only. Some reports may have incomplete information.
Do you take Embeline e and Ranitidine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Embeline e (37 reports)
- Ranitidine (234,475 reports)
Browse all drug interactions of Embeline e and Ranitidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Embeline e:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ranitidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Embeline e and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ranitidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on clobetasol propionate and ranitidine (the active ingredients of Embeline e and Ranitidine, respectively), and Embeline e and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Isoniazid and Lexapro - 5 seconds ago
- Imipramine Hydrochloride vs. Nucynta, side effect and effectiveness comparison - 6 seconds ago
- Could Lidocaine And Prilocaine cause Drowsiness? - 6 seconds ago
- Drug interactions of Novolog and Polyethylene Glycol 3350 - 14 seconds ago
- Could Yaz cause Kidney Stones? - 20 seconds ago
- Drug interactions of Chlorpheniramine Maleate and Norco - 22 seconds ago
- Drug interactions of Hydroxyzine and Periogard - 22 seconds ago
- Could Amisulpride cause Organic Brain Syndrome? - 24 seconds ago
- Could Levothyroxine Sodium cause Osteoarthritis Aggravated? - 30 seconds ago
- Could Yasmin cause Intra-Uterine Death? - 30 seconds ago